|
Title
|
|
|
|
Results of two worldwide surveys into physician awareness and perceptions of extended-spectrum β-lactamases
| |
|
Author
|
|
|
|
| |
|
Institution/Organisation
|
|
|
|
MYSTIC Study Group
| |
|
Abstract
|
|
|
|
| An omnibus survey of microbiologists (n = 400) and a survey of participants (n = 49) in the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme were conducted to determine the awareness and prevalence of extended-spectrum â-lactamases (ESBLs), and the regularity and method of screening. Of the omnibus survey participants, 69% screened regularly for ESBLs, compared with 83% of MYSTIC participants. In both surveys, ESBLs were more common in Klebsiella pneumoniae (73% and 79%, respectively) and Escherichia coli (63% and 81%, respectively) than in other bacteria. The surveys demonstrated that awareness of, and testing for, ESBLs is inconsistent. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Clinical microbiology and infection / European Society of Clinical Microbiology and Infectious Diseases. - Oxford
| |
|
Publication
|
|
|
|
Oxford
:
2004
| |
|
ISSN
|
|
|
|
1198-743X
[print]
1469-0691
[online]
| |
|
DOI
|
|
|
|
10.1111/J.1469-0691.2004.00957.X
| |
|
Volume/pages
|
|
|
|
10
:8
(2004)
, p. 760-762
| |
|
ISI
|
|
|
|
000223894900013
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|